A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma
- DOI
- 10.1038/s41408-026-01616-6
- Published
- 2026-09-03
- Container
- Blood Cancer Journal
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41408-026-01616-6,
title = {A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma},
author = {Ricardo Ahrens and Kyra Ahrens and Maximilian Al-Bazaz and Lisa Leypoldt and Carsten Bokemeyer and Winfried Alsdorf and Katja Weisel},
year = {2026},
journal = {Blood Cancer Journal},
doi = {10.1038/s41408-026-01616-6},
url = {https://doi.org/10.1038/s41408-026-01616-6}
}RIS
TY - JOUR TI - A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma AU - Ricardo Ahrens AU - Kyra Ahrens AU - Maximilian Al-Bazaz AU - Lisa Leypoldt AU - Carsten Bokemeyer AU - Winfried Alsdorf AU - Katja Weisel PY - 2026 JO - Blood Cancer Journal DO - 10.1038/s41408-026-01616-6 UR - https://doi.org/10.1038/s41408-026-01616-6 ER -
APA
Ahrens, R., Ahrens, K., Al-Bazaz, M., Leypoldt, L., Bokemeyer, C., Alsdorf, W., & Weisel, K. (2026). A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma. Blood Cancer Journal. https://doi.org/10.1038/s41408-026-01616-6
Source records
- crossref · retrieved 2026-09-25T15:25:07.263Z